Canavan Disease

Canavan disease, a type of leukodystrophy, is an autosomal recessive neurodegenerative disorder, and is one of the most common degenerative cerebral diseases of infancy. Discover the latest research on Canavan disease here.

December 17, 2019
Case Report

A case of juvenile Canavan disease with distinct pons involvement

Brain & Development
Nafiye Emel Çakar, Tuğçe Aksu Uzunhan
August 26, 2018
Open Access

Neonatal testis growth recreated in vitro by two-dimensional organ spreading

Biotechnology and Bioengineering
Kazuaki KojimaTakehiko Ogawa
December 15, 2020
Open Access

Current Clinical Applications of in vivo Gene Therapy with AAVs

Molecular Therapy : the Journal of the American Society of Gene Therapy
Jerry R MendellJacques P Tremblay
September 1, 2018
Clinical Trial
Open Access

Therapeutic hypothermia to reduce intracranial pressure after traumatic brain injury: the Eurotherm3235 RCT

Health Technology Assessment : HTA
Peter Jd AndrewsGordon Murray
February 27, 2020
Open Access

Management of Neuroinflammatory Responses to AAV-Mediated Gene Therapies for Neurodegenerative Diseases

Brain Sciences
Barbara A PerezManuela Corti
October 9, 2020
Open Access

NGS based expanded pilot carrier screening study in North Indian population reveals unexpected results.

Kanika SinghIshwar Chander Verma
December 12, 2020
Open Access

Cell-Based Therapy for Canavan Disease Using Human iPSC-Derived NPCs and OPCs

Advanced Science
Lizhao FengYanhong Shi
October 19, 2018
Case Report
Open Access

A case report of Creutzfeldt-Jakob disease

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
O V KurushinaP S Krivonozhkina
March 6, 2019
Open Access

First Record Mutations in the Genes ASPA and ARSA Causing Leukodystrophy in Jordan

BioMed Research International
Tawfiq Froukh
September 19, 2018
Open Access

The PIN-FORMED Auxin Efflux Carriers in Plants

International Journal of Molecular Sciences
Jing-Jing Zhou, Jie Luo
September 24, 2019

Distinguishing Encephaloclastic Lesions Resulting From Primary or Secondary Pyruvate Dehydrogenase Deficiency From Other Neonatal or Infantile Cavitary Brain Lesions

Pediatric and Developmental Pathology : the Official Journal of the Society for Pediatric Pathology and the Paediatric Pathology Society
Ahmed GilaniBette K Kleinschmidt-DeMasters
November 4, 2020
Open Access

NGS-based expanded carrier screening for genetic disorders in North Indian population reveals unexpected results - a pilot study

BMC Medical Genetics
Kanika SinghIshwar Chander Verma
August 18, 2018
Open Access

The Protean Acremonium . A. sclerotigenum/egyptiacum : Revision, Food Contaminant, and Human Disease

Richard C SummerbellJames A Scott
December 12, 2018

Pathophysiology and Treatment of Canavan Disease

Neurochemical Research
David PleasureVanessa Hull
November 16, 2018

Allosteric Control of N-Acetyl-Aspartate Hydrolysis by the Y231C and F295S Mutants of Human Aspartoacylase

Journal of Chemical Information and Modeling
Ekaterina D KotsAlexander V Nemukhin
July 2, 2019
Open Access

Development of bisubstrate analog inhibitors of aspartate N-acetyltransferase, a critical brain enzyme

Chemical Biology & Drug Design
Vinay MutthamsettyRonald E Viola

Sign up to follow this feed and discover related papers.

Related Feeds

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.


TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Acute Disseminated Encephalomyelitis

Acute disseminated encephalomyelitis (ADEM) is a rare inflammatory demyelinating disease of the central nervous system. Discover the latest research on acute disseminated encephalomyelitis here.


Adrenoleukodystrophy (ALD), the most frequent peroxisomal disorder, is an X-linked disorder caused by a defect in the metabolism of long chain fatty acids leading to demyelination, neurodegeneration, and death. Here is the latest research.

© 2021 Meta ULC. All rights reserved